Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Dermatologic 1Breast 1

Conditions

Melanoma 112Carcinoma, Non-Small-Cell Lung 26Skin Neoplasms 20Colorectal Neoplasms 17Sarcoma 15Lung Neoplasms 15Carcinoma, Renal Cell 15Breast Neoplasms 14Squamous Cell Carcinoma of Head and Neck 13Pancreatic Neoplasms 13Ovarian Neoplasms 13Carcinoma, Merkel Cell 12Urinary Bladder Neoplasms 11Prostatic Neoplasms 11Neoplasms 11Carcinoma, Basal Cell 11Stomach Neoplasms 10Neoplasm Metastasis 10Head and Neck Neoplasms 10Carcinoma, Hepatocellular 10Uterine Cervical Neoplasms 8Thyroid Neoplasms 8Lymphoma, T-Cell, Cutaneous 8Mycosis Fungoides 7Esophageal Neoplasms 7Brain Neoplasms 7Recurrence 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma 6Gastrointestinal Neoplasms 6

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthritis, Rheumatoid × Dermatologic × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡